Stockscreener 앱 받기
7.56
10.04%
0.69
Design Therapeutics Inc 주식(DSGN)의 최신 뉴스
Design Therapeutics (NASDAQ:DSGN) Price Target Raised to $6.00 - Defense World
Why retail investors favor Design Therapeutics Inc. stockWeekly Stock Recap & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-11-08 10:43:24 - newser.com
How to interpret RSI for Design Therapeutics Inc. stockWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Can Design Therapeutics Inc. stock sustain institutional interestJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Technical signs of recovery in Design Therapeutics Inc.Risk Management & Daily Profit Focused Screening - newser.com
Analyzing Design Therapeutics Inc. with risk reward ratio charts2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com
What indicators show strength in Design Therapeutics Inc.Market Sentiment Review & Long-Term Growth Plans - newser.com
Design Therapeutics Posts Narrower Loss And Expands Research Pipeline - Finimize
DSGN: RBC Capital Raises Price Target for Design Therapeutics | - GuruFocus
RBC Raises Price Target on Design Therapeutics to $6 From $5, Keeps Sector Perform, Speculative Risk - MarketScreener
Is Design Therapeutics Inc. stock poised for growthEarnings Risk Report & Verified Trade Idea Suggestions - newser.com
How high can Design Therapeutics Inc. stock goMarket Rally & Expert-Curated Trade Recommendations - newser.com
Why Design Therapeutics Inc. stock could outperform in 2025Entry Point & Low Risk High Reward Trade Ideas - fcp.pa.gov.br
How to integrate Design Therapeutics Inc. into portfolio analysis toolsJuly 2025 Action & Smart Allocation Stock Tips - newser.com
Design Therapeutics Reports Q3 2025 Financial Results - TipRanks
Design Therapeutics unveils DT-818 for myotonic dystrophy treatment By Investing.com - Investing.com Nigeria
Should you wait for a breakout in Design Therapeutics Inc.Trade Performance Summary & Smart Swing Trading Techniques - newser.com
Will Design Therapeutics Inc. stock outperform tech sector in 2025Rate Hike & Momentum Based Trading Ideas - fcp.pa.gov.br
Forecasting Design Therapeutics Inc. price range with options data2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
Developing predictive dashboards with Design Therapeutics Inc. dataMarket Growth Review & Step-by-Step Trade Execution Guides - newser.com
Design Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Design Therapeutics' reports lower-than-expected Q3 loss - MarketScreener
Design Therapeutics unveils DT-818 for myotonic dystrophy treatment - Investing.com
Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results - The Manila Times
Design (NASDAQ: DSGN) gains ex-US regulatory clearance; DT-818 dosing DM1 H1 2026 - Stock Titan
Is Design Therapeutics Inc. forming a bottoming baseShort Setup & Smart Money Movement Alerts - newser.com
What recovery options are there for Design Therapeutics Inc.2025 Macro Impact & Consistent Income Trade Ideas - newser.com
Regression analysis insights on Design Therapeutics Inc. performance2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com
Design Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 - Yahoo Finance
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
How to recover losses in Design Therapeutics Inc. stockWeekly Trade Report & Weekly Sector Rotation Insights - newser.com
Design Therapeutics, Inc. (NASDAQ:DSGN) Short Interest Update - MarketBeat
5.44%
0.70%
자본화:
|
볼륨(24시간):